Literature DB >> 26382992

Hormone therapy and ovarian cancer.

Florence Trémollieres1, Patrice Lopès2, Anne Gompel3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26382992     DOI： 10.1016/S0140-6736(15)00139-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Deregulated miR-296/S100A4 axis promotes tumor invasion by inducing epithelial-mesenchymal transition in human ovarian cancer.

Authors:  Wang Yan; Jiaqi Chen; Zhaoying Chen; Huimin Chen
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

2.  Let-7d increases ovarian cancer cell sensitivity to a genistein analog by targeting c-Myc.

Authors:  Ying-Xia Ning; Xin Luo; Meng Xu; Xin Feng; Jian Wang
Journal:  Oncotarget       Date:  2017-08-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.